I am a
Home I AM A Search Login

Papers of the Week


2020 Apr


Pediatr Blood Cancer


67


4

Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.

Authors

Badia P, Ricci K, Gurria JP, Dasgupta R, Patel M, Hammill A
Pediatr Blood Cancer. 2020 Apr; 67(4):e28088.
PMID: 31930696.

Abstract

Vascular anomalies (VA), characterized by the abnormal development or growth of blood and/or lymphatic vessels, encompasses a spectrum of conditions with a range of symptoms and complications. VA are frequently associated with cutaneous complications that can cause significant morbidity. Systemic sirolimus has previously been shown to be effective in the treatment of complicated VA. There are limited studies to date on the use of topical sirolimus for the treatment of cutaneous manifestations of VA.